BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Mar 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-03-13

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-13	Common Stock	F	30952	$84.50	Disposed	265491	Direct
2020-03-16	Common Stock	A	44850	—	Acquired	310341	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-16	Stock Option (Right to buy Common Stock	$73.82	A	127920	Acquired	2030-03-15	Common Stock (127920)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247958	Indirect

Footnotes

F1: Restricted stock units granted on March 16, 2020. Price not applicable.

F2: Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter.